A Prospective, Open, Single-arm, Multicenter Phase II Clinical Trial to Evaluate the Tumour Response and Safety in Patients With Advanced Primary Hepatocellular Carcinoma Treated With AMT2003
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2013
At a glance
- Drugs AMT 2003 (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Feb 2007 New trial record.